Showcasing Insect Cell-Based AAV Manufacturing Capabilities to Enable Scalable Clinical & Commercial Production
11:45 am - Thursday 25th February 2027
- Demonstrating an insect cell-based AAV production platform with proven process development strategies to achieve robust clinical manufacturing readiness
- Presenting a 1,000L clinical manufacturing case study with regulatory-approved quality outcomes to validate large-scale production performance
- Leveraging scalable 1,000L AAV manufacturing capabilities for neurodegenerative therapies to support broader patient access efficiently
